Healthcare ❯ Pharmaceuticals ❯ Drug Approval

FDA

Bristol Myers Squibb Clinical Trials Lenacapavir Johnson & Johnson Esketamine SPRAVATO Global Health Monoclonal Antibodies Neffy Vaccine Oversight Novo Nordisk Wegovy Regulatory Affairs KYGEVVI Familial Chylomicronemia Syndrome New Drug Mechanisms

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

The decision follows a Priority Review that cited modest benefit, with the alcohol-related safety warning unchanged.

Arrowhead Gains FDA Approval for Redemplo as Results Surge and Shares Hit Three-Year High

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention